{"id":41326,"date":"2024-04-25T11:59:11","date_gmt":"2024-04-25T09:59:11","guid":{"rendered":"https:\/\/www.satt.fr\/satt-up-avril-2024\/"},"modified":"2024-04-25T16:09:30","modified_gmt":"2024-04-25T14:09:30","slug":"satt-up-avril-2024","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024"},"content":{"rendered":"<div id=\"pl-41326\"  class=\"panel-layout\" ><div id=\"pg-41326-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Retrouvez les derni\u00e8res actualit\u00e9s des startups accompagn\u00e9es par les membres du R\u00e9seau SATT pour les mois d'avril 2024.<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-1-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"1\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images-300x130.png\" class=\"image wp-image-41314  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/images.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-1-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Vertex et TreeFrog Therapeutics annoncent un accord de licence et une collaboration visant \u00e0 optimiser la production des th\u00e9rapies cellulaires de Vertex pour le diab\u00e8te de type 1, avec un accord record de 730M\u20ac.<\/strong>\u00a0<em>(Aquitaine Science Transfert)<\/em><\/p>\n<p>Vertex Pharmaceuticals Incorporated (Nasdaq : VRTX) et TreeFrog Therapeutics ont annonc\u00e9 aujourd'hui que Vertex a obtenu une licence exclusive pour la technologie de fabrication cellulaire brevet\u00e9e de TreeFrog, C-Stem\u2122, afin d'optimiser la production des th\u00e9rapies cellulaires de Vertex pour le diab\u00e8te de type 1 (T1D). TreeFrog et Vertex vont collaborer pour d\u00e9velopper le processus de TreeFrog afin de produire et d'amplifier les cellules pour les th\u00e9rapies de Vertex pour le diab\u00e8te de type 1.<\/p>\n<p><a href=\"https:\/\/treefrog.fr\/\">treefrog.fr<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-2-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"3\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok-300x130.png\" class=\"image wp-image-41312  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Dextrain-ok.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-2-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"4\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Dextrain HomeRehab au domicile : une r\u00e9volution de la r\u00e9\u00e9ducation de la dext\u00e9rit\u00e9 manuelle.<\/strong> <em>(Erganeo)<\/em><\/p>\n<p>Dextrain annonce la sortie de son nouvel appareil d\u00e9di\u00e9 \u00e0 l'entrainement de la dext\u00e9rit\u00e9 \u00e0 domicile : le HomeRehab. A cette occasion, une pr\u00e9sentation \u00e0 l'Institut du Cerveau est organis\u00e9 le 29 avril. Le HomeRehab repr\u00e9sente une avanc\u00e9e significative dans le domaine de la r\u00e9\u00e9ducation de la dext\u00e9rit\u00e9 manuelle, en particulier pour les individus confront\u00e9s \u00e0 des d\u00e9ficits moteurs apr\u00e8s un accient vasculaire c\u00e9r\u00e9bral (AVC).<\/p>\n<p><a href=\"https:\/\/dextrain.com\/\">dextrain.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-3\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-3-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"5\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo-300x130.png\" class=\"image wp-image-41310  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/3deus-dynamics-6341-logo.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-3-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-3-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"6\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Une r\u00e9volution dans l'impression 3D Culinaire : 3Deus Dynamics et la P\u00e2tisserie Num\u00e9rique red\u00e9finissent les Normes.<\/strong> <em>(PULSALYS)<\/em><\/p>\n<p>3Deus Dynamics signe un accord avec la P\u00e2tisserie Num\u00e9rique pour repousser les limites de l'impression culinaire. Avec son proc\u00e9d\u00e9 de Moulage Dynamique, 3Deus Dynamics offre \u00e0 la P\u00e2tisserie Num\u00e9rique la possibilit\u00e9 de cr\u00e9eer des p\u00e2tisseries d'une pr\u00e9cision et d'une finesse incomparables, pr\u00e9servant ainsi les saveurs originales et ouvrant la voie \u00e0 une nouvelle \u00e8re de cr\u00e9ativit\u00e9 et d'innovation dans le domaine de la p\u00e2tisserie.<\/p>\n<p><a href=\"https:\/\/www.3deusdynamics.com\/fr\/\">3deusdynamics.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-4\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-4-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"7\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1-300x130.png\" class=\"image wp-image-41316  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/LOGO-OCCENTIS-1.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-4-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-4-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"8\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Occentis SAS, nouvelle startup propuls\u00e9e par la SATT Conectus, d\u00e9veloppe une nouvelle th\u00e9rapie prometteuse pour le traitement de l\u2019autisme, des douleurs neuropathiques et de la d\u00e9pendance \u00e0 l\u2019alcool.<\/strong>\u00a0<em>(Conectus)<\/em><\/p>\n<p>La SATT Conectus a sign\u00e9 une licence exclusive avec Occentis SAS, une toute nouvelle startup soutenue par Neurentis plc et d\u00e9di\u00e9e au d\u00e9veloppement d\u2019un nouveau candidat-m\u00e9dicament issu de travaux de recherche du Laboratoire d\u2019Innovation Th\u00e9rapeutique (UMR 7200 CNRS - Universit\u00e9 de Strasbourg). Les r\u00e9sultats pr\u00e9cliniques confirment un potentiel th\u00e9rapeutique majeur pour la prise en charge des troubles autistiques, des douleurs neuropathiques et le sevrage alcoolique.<\/p>\n<p><a href=\"http:\/\/occentis.com\/\">occentis.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-5\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-5-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-5-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"9\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-300x130.png\" class=\"image wp-image-41322  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-5-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-5-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"10\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><b>Ventilation liquidienne : Orixha leve 4 millions d\u2019euros aupr\u00e8s de l\u2019EIC Fund et de Bpifrance.<\/b>\u00a0<em>(Erganeo)<\/em><\/p>\n<p>Orixha annonce une lev\u00e9e de 4 millions d\u2019euros aupr\u00e8s de l\u2019European Innovation Council Fund et du fonds French Tech Seed, g\u00e9r\u00e9 pour le compte de l'\u00c9tat par Bpifrance dans le cadre de France 2030. Ce financement perm et \u00e0 Orixha de d\u00e9velopper et de valider en clinique sa technologie de ventilation liquidienne totale pour la prise en charge en soins intensifs de l\u2019arr\u00eat cardiaque r\u00e9anim\u00e9.<\/p>\n<p><a href=\"https:\/\/orixha.com\/\">orixha.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-6\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-6-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-6-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"11\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain-300x130.png\" class=\"image wp-image-41318  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/Rebrain.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-6-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-6-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"12\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><b>RebrAIn l\u00e8ve 3,7 millions d\u2019euros pour son logiciel simplifiant le travail des neurochirurgiens.<\/b>\u00a0<em>(Aquitaine Science Transfert)<\/em><\/p>\n<p>La start-up bordelaise RebrAIn d\u00e9veloppe un logiciel SaaS permettant aux neurochirurgiens de mieux cibler les zones du cerveau lors d\u2019op\u00e9rations de stimulation c\u00e9r\u00e9brale profonde gr\u00e2ce \u00e0 un algorithme d\u2019identification de points. Elle l\u00e8ve des fonds pour acc\u00e9l\u00e9rer son d\u00e9veloppement commercial, conqu\u00e9rir le march\u00e9 am\u00e9ricain et continuer d'investir dans la R&amp;D.<\/p>\n<p><a href=\"https:\/\/rebrain.eu\/\">rebrain.eu<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-41326-7\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-41326-7-0\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-7-0-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"13\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"130\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1-300x130.png\" class=\"image wp-image-41320  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1-300x130.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1-150x65.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1-500x217.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1-200x87.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/04\/telechargement-1.png 569w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><div id=\"pgc-41326-7-1\"  class=\"panel-grid-cell\" ><div id=\"panel-41326-7-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"14\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><b>La start- up Methys Dx sous les projecteurs.<\/b>\u00a0<em>(Erganeo)<\/em><\/p>\n<p>En ce d\u00e9but d'ann\u00e9e, la start-up METHYS Dx, sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de la m\u00e9decine personnalis\u00e9e en oncologie gr\u00e2ce \u00e0 des techniques de suivi non invasives, a attir\u00e9 l'attention : Le magazine Challenges a nomin\u00e9 METHYS Dx parmi les 100 start-ups o\u00f9 investir en 2024, dans la cat\u00e9gorie Biotech. \u00c0 la fin de mars, la start-up s'est retrouv\u00e9e finaliste dans la cat\u00e9gorie \"Diagnostic M\u00e9dical\" du Troph\u00e9e de la Healthtech 2024 d\u00e9cern\u00e9 par France Biotech. En mars, Val\u00e9rie Taly, PDG de la start-up, a \u00e9t\u00e9 mentionn\u00e9e dans le Palmar\u00e8s des Inventeurs 2024 d\u00e9cern\u00e9 par le magazine Le Point, dans la cat\u00e9gorie \"biotech\".<\/p>\n<p><a href=\"https:\/\/methysdx.com\/\">methysdx.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Retrouvez les derni\u00e8res actualit\u00e9s des startups accompagn\u00e9es par les membres du R\u00e9seau SATT pour les mois d&#8217;avril 2024. Vertex et TreeFrog Therapeutics annoncent un accord de licence et une collaboration visant \u00e0 optimiser la production des th\u00e9rapies cellulaires de Vertex pour le diab\u00e8te de type 1, avec un accord record de 730M\u20ac.\u00a0(Aquitaine Science Transfert) Vertex [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":30126,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,604],"tags":[],"class_list":["post-41326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024\",\"datePublished\":\"2024-04-25T09:59:11+00:00\",\"dateModified\":\"2024-04-25T14:09:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\"},\"wordCount\":824,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png\",\"articleSection\":[\"News\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\",\"url\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png\",\"datePublished\":\"2024-04-25T09:59:11+00:00\",\"dateModified\":\"2024-04-25T14:09:30+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png\",\"width\":3200,\"height\":1785},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024","datePublished":"2024-04-25T09:59:11+00:00","dateModified":"2024-04-25T14:09:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/"},"wordCount":824,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","articleSection":["News","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/","url":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/","name":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","datePublished":"2024-04-25T09:59:11+00:00","dateModified":"2024-04-25T14:09:30+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","width":3200,"height":1785},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-avril-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #49 \u2013 Avril 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/41326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=41326"}],"version-history":[{"count":2,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/41326\/revisions"}],"predecessor-version":[{"id":41347,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/41326\/revisions\/41347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/30126"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=41326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=41326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=41326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}